4.06 M
About GLOBEIMMUNE INC
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GBIM is 0.000001 USD — it hasn't changed in the past 24 hours. Watch GLOBEIMMUNE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GLOBEIMMUNE INC stocks are traded under the ticker GBIM.
GBIM reached its all-time high on Jul 14, 2014 with the price of 15.000000 USD, and its all-time low was 0.000001 USD and was reached on Feb 6, 2024. View more price dynamics on GBIM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GBIM stock is 0.00% volatile and has beta coefficient of −0.67. Track GLOBEIMMUNE INC stock price on the chart and check out the list of the most volatile stocks — is GLOBEIMMUNE INC there?
Yes, you can track GLOBEIMMUNE INC financials in yearly and quarterly reports right on TradingView.
No, GBIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GBIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLOBEIMMUNE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLOBEIMMUNE INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLOBEIMMUNE INC stock shows the sell signal. See more of GLOBEIMMUNE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.